These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35469915)

  • 21. Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium.
    Ma Y; Wang Z; Zhao W; Lu T; Wang R; Mei Q; Chen T
    Int J Nanomedicine; 2013; 8():2351-60. PubMed ID: 23847417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study.
    Hu Y; Rip J; Gaillard PJ; de Lange ECM; Hammarlund-Udenaes M
    J Pharm Sci; 2017 Sep; 106(9):2606-2613. PubMed ID: 28322936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of liposomal formulation on the incorporation and retention of PNA oligomers.
    Ringhieri P; Avitabile C; Saviano M; Morelli G; Romanelli A; Accardo A
    Colloids Surf B Biointerfaces; 2016 Sep; 145():462-469. PubMed ID: 27236097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of liposomal phospholipids and lipid transport-related protein on the intracellular fate of encapsulated doxorubicin.
    Un K; Sakai-Kato K; Kawanishi T; Okuda H; Goda Y
    Mol Pharm; 2014 Feb; 11(2):560-7. PubMed ID: 24383572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
    Patel GB; Sprott GD
    Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
    Yang K; Mesquita B; Horvatovich P; Salvati A
    Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.
    Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
    Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomal drug formulations in the treatment of rheumatoid arthritis.
    van den Hoven JM; Van Tomme SR; Metselaar JM; Nuijen B; Beijnen JH; Storm G
    Mol Pharm; 2011 Aug; 8(4):1002-15. PubMed ID: 21634436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlling the size and shape of liposomal ciprofloxacin nanocrystals by varying the lipid bilayer composition and drug to lipid ratio.
    Li T; Clulow AJ; Nowell CJ; Hawley A; Cipolla D; Rades T; Boyd BJ
    J Colloid Interface Sci; 2019 Nov; 555():361-372. PubMed ID: 31398564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
    Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
    ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposome co-encapsulation as a strategy for the delivery of curcumin and resveratrol.
    Huang M; Liang C; Tan C; Huang S; Ying R; Wang Y; Wang Z; Zhang Y
    Food Funct; 2019 Oct; 10(10):6447-6458. PubMed ID: 31524893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells.
    Abumanhal-Masarweh H; da Silva D; Poley M; Zinger A; Goldman E; Krinsky N; Kleiner R; Shenbach G; Schroeder JE; Shklover J; Shainsky-Roitman J; Schroeder A
    J Control Release; 2019 Aug; 307():331-341. PubMed ID: 31238049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encapsulation of phytosterols and phytosterol esters in liposomes made with soy phospholipids by high pressure homogenization.
    Wang FC; Acevedo N; Marangoni AG
    Food Funct; 2017 Nov; 8(11):3964-3969. PubMed ID: 28972217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paramagnetic liposomes as magnetic resonance imaging contrast agents. Assessment of contrast efficacy in various liver models.
    Fossheim SL; Colet JM; Månsson S; Fahlvik AK; Muller RN; Klaveness J
    Invest Radiol; 1998 Nov; 33(11):810-21. PubMed ID: 9818315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.
    Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S
    Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
    Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
    Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
    Schroeder A; Kost J; Barenholz Y
    Chem Phys Lipids; 2009 Nov; 162(1-2):1-16. PubMed ID: 19703435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparison of Cellular Uptake Mechanisms, Delivery Efficacy, and Intracellular Fate between Liposomes and Extracellular Vesicles.
    Gandek TB; van der Koog L; Nagelkerke A
    Adv Healthc Mater; 2023 Oct; 12(25):e2300319. PubMed ID: 37384827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.